Free Delivery on all orders over £39 *Exclusions Apply*

Product image

Librela solution for injection

£79.99£91.99

Librela is an innovative drug that helps alleviate the pain associated with osteoarthritis in dogs.

This is a refrigerated product and therefore will need to be sent by courier with someone available to sign for the package upon delivery.  Contents must be refrigerated upon delivery.

A pack of 10 needles and syringes can be purchased here for use with this product

Legal category POM-V

Read More

Prescriptions

  • I will provide my prescription by: *

  • Email prescription *

    Please e-mail your prescription to [email protected]
  • Post prescription *

    Please send to: Dr Nicola Endersby MRCVS, Cura, 4 Saxon Court, Bishop Auckland DL14 7UA
  • Vet will send directly *

    Please ask your vet to e-mail your prescription to [email protected] with your name and order number as a reference. (You will receive your order number once you have completed your purchase) Please confirm your Vet Practice name below
  • Your vet practice: *

  • Prescription *

    Please upload your prescription for this product.Max file size: 25 MBPermitted file types: jpg jpeg jpe gif png pdf

  • Animal name(s) *

Product total

Options total

Grand total

View POM

Delivery

All orders over £39 receive free delivery * *terms and conditions apply

Returns

Returns It should be noted that, unfortunately, we cannot accept returns of any labelled products, including prescription medicines and flea and worming products. If the customer has requested a cancellation but the order has already been dispatched then we will not be able to cancel and refund the order. This also applies if the customer has ordered the incorrect dosage. Returns of any labelled products are only acceptable if it is due to an error in processing, or for an official recall. We are also unable to accept the returns of Caninsulin syringes, even if the packaging is unopened.

View More

Description

Librela is an innovative drug for the alleviation of pain associated with osteoarthritis in dogs. The medication contains a canine monoclonal antibody (mAb) which targets nerve growth factor (NGF). This inhibits NGF-mediated cell signalling which has been demonstrated to provide relief from pain associated with osteoarthritis. The product is administered by monthly injection and has been proven to reduce pain scores in dogs with osteoarthritis.

Dosage and administration
For subcutaneous use.
Dosage and treatment schedule
  • The recommended dose is 0.5-1.0 mg/kg bodyweight, once a month.
  • For dogs weighing <5.0 kg aseptically withdraw 0.1 ml/kg from a single 5 mg/ml vial and administer subcutaneously.
For dogs between 5 and 60 kg administer the entire content of the vial (1 ml) according to the table below:
LIBRELA strength (mg) to be administered
Bodyweight (kg) of dog
5
10
15
20
30
5.0 – 10.0
1 vial
10.1 – 20.0
1 vial
20.1 – 30.0
1 vial
30.1 – 40.0
1 vial
40.1 – 60.0
1 vial
60.1 – 80.0
2 vials
80.1 – 100.0
1 vial
1 vial
100.1 – 120.0
2 vials
For dogs above 60 kg, the contents of more than one vial are required to administer a single dose. In those cases, withdraw the content from each required vial into the same syringe and administer as a single subcutaneous injection (2 ml).

Needles and syringes will need to be purchased separately

This is a refrigerated product and therefore will need to be sent by courier with someone available to sign for the package upon delivery.  Contents must be refrigerated upon delivery.

SPC